Phytopharm PLC said it is encouraged by the progress of its Alzheimer’s and motor neurone disease products and is in talks with with interested potential licensing partners to undertake longer term studies.
Phytopharm PLC said it is encouraged by the progress of its Alzheimer’s and motor neurone disease products and is in talks with with interested potential licensing partners to undertake longer term studies.
